Finance

The funds will be used to increase product offerings, expand the commercial team and move into the substance use disorder space.  

Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.

The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.

The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.

The company will use the funds to increase research and development efforts to make robotics surgery more accessible.  

Also, an Indian startup that offers generative AI-powered insurance technology solutions has received seed funding.

The companies' boards of directors say the merger will make it easier for people to access affordable healthcare.

Qualified Health secures $30 million to develop genAI in healthcare, VitVio raised $2 million in pre-seed funding, and Allumia Ventures spins off from Providence to become VC firm.   

The supply chain represents 40% of a hospital's budget. The pressure to reduce cost is at an all-time high due in part to slow revenue growth - a major challenge for hospital CFOs - says David Kirshner managing partner at LogicSource.

The editors of Healthcare IT News, Healthcare Finance News and MobiHealthNews discuss the telehealth bill that was scuttled in 2024, as well as what's ahead in 2025 regarding the RPM market, physicians' pay schedule and cybersecurity policy.